Basilicata, M.; Terrano, V.; D'Aurelio, A.; Bruno, G.; Troiani, T.; Bollero, P.; Napolitano, S.
Oral Adverse Events Associated with BRAF and MEK Inhibitors in Melanoma Treatment: A Narrative Literature Review. Healthcare 2024, 12, 105.
https://doi.org/10.3390/healthcare12010105
AMA Style
Basilicata M, Terrano V, D'Aurelio A, Bruno G, Troiani T, Bollero P, Napolitano S.
Oral Adverse Events Associated with BRAF and MEK Inhibitors in Melanoma Treatment: A Narrative Literature Review. Healthcare. 2024; 12(1):105.
https://doi.org/10.3390/healthcare12010105
Chicago/Turabian Style
Basilicata, Michele, Vincenzo Terrano, Alessandro D'Aurelio, Giovanni Bruno, Teresa Troiani, Patrizio Bollero, and Stefania Napolitano.
2024. "Oral Adverse Events Associated with BRAF and MEK Inhibitors in Melanoma Treatment: A Narrative Literature Review" Healthcare 12, no. 1: 105.
https://doi.org/10.3390/healthcare12010105
APA Style
Basilicata, M., Terrano, V., D'Aurelio, A., Bruno, G., Troiani, T., Bollero, P., & Napolitano, S.
(2024). Oral Adverse Events Associated with BRAF and MEK Inhibitors in Melanoma Treatment: A Narrative Literature Review. Healthcare, 12(1), 105.
https://doi.org/10.3390/healthcare12010105
